Histocell inaugurates new manufacturing plant for advanced therapy medicinal products

Histocell ha inaugurado en noviembre su planta de fabricación en Larrabetzu, dedicada a medicamentos de terapia celular y biológicos. La instalación multiplica por diez la capacidad productiva de Histocell en este tipo de productos y en este ámbito constituye una de las plantas de fabricación con mayor capacidad del Estado. El proyecto ha contado con…

GAIKER is working on the detection and treatment of contaminants of emerging concern in water supply and wastewater

The emerGEN project aims to improve knowledge on the current state of the quality of water resources, as well as the effectiveness of different treatments for the elimination of contaminants of emerging concern   The GAIKER Technology Centre, member of the Basque Research & Technology Alliance and the Basque Health Cluster, together with the Consorcio…

Local bio-health R&D&I for the Basque Country

“Meeting for the development of new “Smart Medical Device & Robotics” solutions Public-private collaboration is key to creating competitive “technology clusters”, generating and retaining talent and incorporating innovation The “Innovation in Health Matchmaking” Forum for the development of new “Smart Medical Device & Robotics” solutions was held, November 9, in Donostia – San Sebastian, whose…

The Stanford Ranking once again highlights Eduardo Anitua as the most influential Spanish dentist in the world.

The Stanford University ranking selects the 2% of the most cited researchers in the world according to their scientific trajectory. The new edition also points to Anitua as the most relevant Spanish researcher in dentistry in the last year. Dr. Eduardo Anitua, scientific director of the company BTI Biotechnology Institute, heads the list of thirteen…

Oncomatryx fights cancer with precision medicine

The biotech firm develops the first conjugated antibody in Europe against pancreatic, lung and breast tumours The Basque biotech company Oncomatryx, which specialises in the development of pioneering drugs against invasive tumours, has recently developed the first conjugated antibody in Europe that directly attacks the cells surrounding the tumour. In Spain alone, some 8,700 cases…